EU ‘Pathfinder’ Project Aims To Improve Cancer Drug Development & Assessment
The Pathfinder initiative is intended to accelerate cancer drug development and assessment, strengthen international collaboration, and improve the way the EMA communicates about the benefits and risks of cancer medicines.